Clinical experience of therapy with current antiviral drugs for chronic hepatitis C in the Nizhny Novgorod Region

• Mazhara O.A.
• Ochrytkova T.V.
• Vasenkina V.P.
• Kalinina E.V.
• Menshikov A.Y.

AbstractThe reaL-Life cLinicaL practice of IFN-free therapy combination of paritaperevir, ritonavir-boosted, ombitasvir and dasabuvir in 5 patients with compensated and subcompensated Liver cirrhosis and chronic viraL hepatitis C and data of tripLe therapy with a domestic protease inhibitor narLaprevir in 26 patients with chronic viraL hepatitis C at the Nizhny Novgorod hepatoLogy center is presented in this paper. The most interesting cLinicaL cases from described cohorts are discussed.

Keywords:chronic hepatitis C, IFN-free therapy, IFN-based СНС therapy, direct-acting antivirals, paritaprevir, ombitasvir, dasabuvir, narlaprevir, real-life clinical practice

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)